Chelation therapy is a series of intravenous infusion treatments with a synthetic amino acid known as EDTA. This amino acid bonds to molecules of lead, mercury, calcium, cadmium and other trace minerals in the circulatory system and removes them from the body in the urine.
At the Center for Health and Healing, our protocol is based on the American College for the Advancement of Medicine standards. The ACM is a non-profit organization devoted to research of coronary artery disease treatments. The protocol developed by ACM has been used to treat over a half million patients in the United States.
During chelation therapy, EDTA is given by intravenous infusion in a regimen that involves a number of treatments over a period of time. The number and duration of the treatments varies according to the individual patient.
The routine therapy regimen begins with a series of 30 intravenous infusions. After the first thirty infusions, the patient will receive treatments once or twice in a month to sustain the benefits. This usually continues for about a year, followed by maintenance treatments every few months. The exact regimen will vary for the individual patient and our medical staff evaluates each patient to determine the best course of treatment for that patient.